|
Market Closed -
Warsaw S.E.
11:57:42 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 3.260 PLN | 0.00% |
|
+6.89% | +25.38% |
| 08-26 | Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-28 | Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Company Valuation: Pharmena S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 98.86 | 88.1 | 62.37 | 79.08 | 42.66 | 28.96 |
| Change | - | -10.89% | -29.2% | 26.79% | -46.06% | -32.11% |
| Enterprise Value (EV) 1 | 102.7 | 96.35 | 70.92 | 57.02 | 41.16 | 28.97 |
| Change | - | -6.14% | -26.39% | -19.6% | -27.83% | -29.62% |
| P/E | -14.3x | -19.1x | -39.7x | 2.73x | -33.8x | -10.4x |
| PBR | -711x | -18.1x | -9.61x | 3.51x | 3.43x | 3x |
| PEG | - | 0.6x | 0.6x | -0x | 0x | -0x |
| Capitalization / Revenue | 9.95x | 5.79x | 3.28x | 264x | 159x | 18.4x |
| EV / Revenue | 10.3x | 6.33x | 3.73x | 191x | 154x | 18.4x |
| EV / EBITDA | -17.3x | -25.4x | -173x | 1.73x | -12.2x | -8.89x |
| EV / EBIT | -16.7x | -24x | -137x | 1.74x | -12.2x | -8.83x |
| EV / FCF | -276x | -54x | 120x | 2.84x | -3.39x | -43.1x |
| FCF Yield | -0.36% | -1.85% | 0.83% | 35.3% | -29.5% | -2.32% |
| Dividend per Share 2 | - | - | - | 0.85 | - | - |
| Rate of return | - | - | - | 12% | - | - |
| EPS 2 | -0.63 | -0.4133 | -0.141 | 2.598 | -0.1133 | -0.25 |
| Distribution rate | - | - | - | 32.7% | - | - |
| Net sales 1 | 9.933 | 15.21 | 19.02 | 0.299 | 0.268 | 1.577 |
| EBITDA 1 | -5.938 | -3.791 | -0.41 | 32.88 | -3.362 | -3.257 |
| EBIT 1 | -6.151 | -4.013 | -0.519 | 32.81 | -3.383 | -3.28 |
| Net income 1 | -6.891 | -4.592 | -1.57 | 28.94 | -1.262 | -2.769 |
| Net Debt 1 | 3.788 | 8.249 | 8.551 | -22.05 | -1.501 | 0.009 |
| Reference price 2 | 9.000 | 7.910 | 5.600 | 7.100 | 3.830 | 2.600 |
| Nbr of stocks (in thousands) | 10,985 | 11,138 | 11,138 | 11,138 | 11,138 | 11,138 |
| Announcement Date | 4/12/21 | 3/31/22 | 3/29/23 | 2/29/24 | 3/31/25 | 2/23/26 |
1PLN in Million2PLN
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 9.76M | |
| 28.9x | 4.47x | 18.44x | 2.05% | 234B | |
| 53.62x | 7.66x | 29.41x | 0.23% | 47.03B | |
| 26.22x | 4.8x | 18.6x | 1.27% | 11.2B | |
| 30.91x | 1.55x | 11.5x | 1.78% | 8.79B | |
| 23.92x | 1.72x | 11.01x | 1.12% | 6.48B | |
| 58.14x | 3.49x | 17.02x | -.--% | 6.34B | |
| 13.19x | 1.66x | 9.11x | 3.55% | 3.66B | |
| 23.33x | 2.36x | 12.66x | 2.81% | 3.65B | |
| 21.23x | 2.75x | 13.33x | 3.69% | 2.85B | |
| Average | 31.05x | 3.38x | 15.68x | 1.83% | 32.42B | |
| Weighted average by Cap. | 32.61x | 4.72x | 19.46x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PHR Stock
- Valuation Pharmena S.A.
Select your edition
All financial news and data tailored to specific country editions
